Cha Meditech Co., Ltd. was incorporated after having been divided out of the medical device development business division of Cha Biotech, which is a subsidiary company of the Cha Bio Group, in August 2013. The company is developing and manufacturing a wide range of growth factors, peptides and natural extracts to be used as subsidiary raw materials for medical drugs, and core raw materials for medical devices and cosmetics, etc.
Also, it directly manufactures and sells specialized medical devices, such as cosmetic fillers and adhesion barrier, based on hyaluronic acid cross-linking technique of its own development through research. It is focusing on global business expansion by exporting to various countries around the world through its brands and OEM manufacturing through cooperation with domestic and overseas leading companies as well.

Cha Meditech Co., Ltd. was incorporated after having been divided out of the medical device development business division of Cha Biotech, which is a subsidiary company of the Cha Bio Group, in August 2013. The company is developing and manufacturing a wide range of growth factors, peptides and natural extracts to be used as subsidiary raw materials for medical drugs, and core raw materials for medical devices and cosmetics, etc.

Also, it directly manufactures and sells specialized medical devices, such as cosmetic fillers and adhesion barrier, based on hyaluronic acid cross-linking technique of its own development through research. It is focusing on global business expansion by exporting to various countries around the world through its brands and OEM manufacturing through cooperation with domestic and overseas leading companies as well.

CHA Meditech is equipped with outstanding quality control system certified by GMP by the Ministry of Food & Drug Safety (MFDS) of Korea and European ISO certificate, etc. Moreover, the company is putting in efforts to supply the highest quality products to the market through automated manufacturing facilities and exhaustive facility management.